Joan L Walker MD
Gynecologic Oncology, Hospice & Palliative Medicine
Associate Professor of Obstetrics & Gynecology, University Okla College of Medicine
Join to View Full Profile
825 NE 10th St# OUPB5200Oklahoma City, OK 73104
Phone+1 405-271-7770
Dr. Walker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (Irvine)Fellowship, Gynecologic Oncology, 1988 - 1990- University of California (Irvine)Residency, Gynecologic Oncology, 1986 - 1990
- University of California (Irvine)Fellowship, Gynecologic Oncology, 1986 - 1987
University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 1982 - 1986
David Geffen School of Medicine at UCLAClass of 1982
Certifications & Licensure
OK State Medical License 1990 - 2025
CA State Medical License 1985 - 2020
PA State Medical License 1984 - 2004
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus Start of enrollment: 1996 Apr 01
- Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix Start of enrollment: 1999 Nov 01
- Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer Start of enrollment: 1999 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsLong-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma.Daniela E Matei, Danielle M Enserro, Marcus E Randall, David Mutch, William Small
Journal of Clinical Oncology. 2025-03-20 - Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.Charles A Leath 3rd, Wei Deng, Loren K Mell, Debra L Richardson, Joan L Walker
Gynecologic Oncology. 2025-03-17 - A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB...Victoria L Bae-Jump, Michael W Sill, Paola A Gehrig, Jason D Merker, David L Corcoran
Gynecologic Oncology. 2025-03-07
Press Mentions
Stephenson Cancer Center Gets 2.2 Million Grant to Fund Cervical Cancer PreventionJune 22nd, 2016
Grant Support
- Expression Of MN Protein In Agcus As Potential Biomarker Of Dysplasia/NeoplasiaNational Center For Research Resources2004–2006
- A Study To Understand Cervical Cancer Early Endpoints And Determinants (SUCCEED)National Center For Research Resources2005
- Prevalence Of Symptoms Suggestive Of Ovarian CancerNational Center For Research Resources2004–2005
- Outcomes In Gynecologic CancerNational Center For Research Resources2004–2005
- Study To Understand Cervical Cancer Early Endpoints AnNational Center For Research Resources2004
- Pivotal Study II: Single-Arm Multi-Ctr. Study Of ODS As Adjunct To ColposcopyNational Center For Research Resources2004
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
